Image 1_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
<p>Type 2 diabetes (T2DM) and tuberculosis (TB) both regulate inflammation and may exert synergistic or antagonistic effects through shared immune pathways. Previous studies have demonstrated that T2DM is a risk factor for TB. However, at the level of gene regulatory networks, it remains uncle...
Wedi'i Gadw mewn:
| Prif Awdur: | Qianqian Du (5773832) (author) |
|---|---|
| Awduron Eraill: | Kun Liu (148201) (author), Yanling Li (269030) (author), Xinyan Wang (170927) (author), Xin Liu (43569) (author), Jing Zhao (21160) (author), Xuemei Wang (39992) (author) |
| Cyhoeddwyd: |
2025
|
| Pynciau: | |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Image 3_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
gan: Qianqian Du (5773832)
Cyhoeddwyd: (2025) -
Image 2_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
gan: Qianqian Du (5773832)
Cyhoeddwyd: (2025) -
Image 4_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
gan: Qianqian Du (5773832)
Cyhoeddwyd: (2025) -
Image 5_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
gan: Qianqian Du (5773832)
Cyhoeddwyd: (2025) -
Image 7_Inhibition of CYP450 family 1 subfamily B member 1 (CYP1B1) expression in macrophage reduces the inflammatory response in type 2 diabetes mellitus combined with tuberculosis.tif
gan: Qianqian Du (5773832)
Cyhoeddwyd: (2025)